Business Context and Reporting Period
Company: Reinsurance Group of America, Inc. (RGA)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2006
Business Overview: RGA is a holding company primarily engaged in life reinsurance, providing mortality risk management and capital management solutions to insurers globally. Operations are segmented into U.S., Canada, Europe & South Africa, Asia Pacific, and Corporate & Other. The company also maintains discontinued accident and health operations.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended June 30, 2006 | Six Months Ended June 30, 2005 |
|---|---|---|
| Net Premiums | $2,069,045 | $1,833,174 |
| Total Revenues | $2,441,633 | $2,187,548 |
| Net Income | $132,701 | $88,374 |
| Income from Continuing Operations | $134,369 | $92,424 |
| Diluted EPS (Net Income) | $2.12 | $1.39 |
| Operating Cash Flow | $307,919 | $202,885 |
| Total Assets | $17,816,667 | $16,193,866 |
| Total Liabilities | $15,350,646 | $13,666,382 |
| Stockholders' Equity | $2,466,021 | $2,527,484 |
| Invested Assets | $13,434,595 | $11,289,159 (Derived from prior year context) |
Note: Prior year invested assets derived from text stating a 20.1% increase to $13.4 billion.
Material Changes vs. Prior Period
- Profitability Surge: Net income increased 50.2% year-over-year ($132.7M vs. $88.4M). Income from continuing operations before taxes rose 54.4% to $205.6M, driven primarily by improved mortality experience in the U.S. and Europe & South Africa segments compared to high claim levels in 2005.
- Revenue Growth: Net premiums grew 12.9% to $2.07 billion due to growth in life reinsurance in force. Investment income increased 17.2% to $355.5M, attributed to a larger invested asset base.
- Asset Expansion: Total invested assets increased 20.1% to $13.4 billion. This was largely driven by an $852.3 million increase in "other invested assets" related to a new $850 million collateral finance facility established in June 2006.
- Segment Performance:
- U.S. Operations: Income before taxes increased 58.0% to $151.3M, fueled by improved mortality and premium growth.
- Europe & South Africa: Turned a loss of $6.8M in Q2 2005 into a profit of $17.3M in Q2 2006 due to favorable mortality in the UK.
- Canada: Income before taxes decreased 26.3% year-over-year due to unfavorable mortality experience, despite premium growth.
- Asia Pacific: Income remained relatively flat for the six-month period, though Q2 income dropped 32.1% due to higher claims in New Zealand.
- Capital Allocation Change: Effective Jan 1, 2006, the company changed its segment capital allocation method from regulatory capital to an internal economic capital model. Prior period results were adjusted to conform.
Guidance, Outlook, Risks, and Unusual Items
- Collateral Finance Facility: On June 28, 2006, a subsidiary issued $850 million of floating rate notes to fund collateral requirements for statutory reserves. Proceeds are restricted and not available for general obligations.
- Accounting Changes: The company adopted SFAS 123(r) for share-based payments, increasing compensation expense by approximately $1.7 million in Q1 2006. It also adopted SFAS 155 regarding hybrid instruments, which had no material impact.
- Legal Proceedings: The company is involved in several arbitrations regarding discontinued accident and health business and life reinsurance. Claims raised by parties total $32.0 million, which is $27.9 million in excess of current reserves. Management believes outcomes will not have a material adverse effect on financial position but could impact quarterly net income.
- Investment Risks: The company holds $181.2 million in gross unrealized losses on fixed maturity and equity securities, primarily due to rising interest rates. Management does not consider these other-than-temporary impairments. The portfolio is 96.8% investment grade.
- Liquidity: Management believes liquidity is sufficient to cover claims and obligations. The company maintains a $600 million syndicated credit facility with $50 million outstanding as of June 30, 2006.
- Forward-Looking Risks: Key risks include adverse mortality/morbidity changes, credit rating downgrades (including MetLife, a majority shareholder), economic downturns affecting demand, and foreign currency fluctuations.
Investor Verification Checklist
- Mortality Assumptions: Verify the sustainability of the improved mortality experience in the U.S. and Europe segments, as this was the primary driver of the 54% increase in pre-tax income.
- Collateral Facility Impact: Review the terms and risks associated with the new $850 million collateral finance facility and its impact on future cash flows and leverage.
- Legal Reserves: Monitor the status of the $27.9 million excess claims in discontinued operations and life reinsurance arbitrations to assess potential reserve adequacy.
- Investment Portfolio Quality: Assess the $181.2 million in unrealized losses to ensure they remain temporary and do not require future write-downs.
- Capital Allocation Model: Understand the implications of the shift to the economic capital model on future segment profitability reporting and capital deployment.